Ultrasensitive assay to detect loiasis onchocerciasis and lymphatic filariasis
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Centers for Disease Control and Prevention
- Recipient company
- NANOCOMPOSIX, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- EVQMBF7KC8P3
- Solicitation number
- Not reported
- Topic code
- ODCDC
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Obscurant Material Drying Processes
- THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION CO
- A point of care test for TB antibiotic concentration in blood
- Rapid diagnostic to determine CMV serological status
- New Carriers Used as Adjuvants for Controlled HIV Immunogen Delivery into Targeted Antigen Presenting Cells
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Community Based Worksite Wellness App Linking Employees to Wellness Resources Zenji
- Nitric Oxide Releasing Ultra Slippery Antibacterial Surfaces for Indewelling Catheter Applications
- Developing a Point of CarePOCLateral Flow AssayLFAto Detect Taenia Solium
- Fluorescent Qdot Immunochromatographic Test Strips for Influenza A B and Group A Strep
- Development of a Benchtop Laboratory Platform for Amplicon Deep Sequencing
Research funding history
50 SBIR/STTR records share this UEI (2005–2020). Reported award amounts total $19,180,547. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration